Bio-Rad Laboratories (BIO) Free Cash Flow (QoQ) (2009 - 2026)
Bio-Rad Laboratories (BIO) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn |
| 10 | Bio-Rad Laboratories | 8.58 Bn | 7.01 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.42% |
| Dec 31, 2025 | 33.52% |
| Sep 30, 2025 | 25.99% |
| Jun 30, 2025 | -25.86% |
| Mar 31, 2025 | 17.47% |
| Dec 31, 2024 | -34.12% |
| Sep 30, 2024 | 123.15% |
| Jun 30, 2024 | 86.82% |
| Mar 31, 2024 | -23.59% |
| Dec 31, 2023 | -27.76% |
| Sep 30, 2023 | -15.47% |
| Jun 30, 2023 | 1.68% |
| Mar 31, 2023 | 39.28% |
| Dec 31, 2022 | 370.11% |
| Sep 30, 2022 | -146.11% |
| Jun 30, 2022 | 106.55% |
| Mar 31, 2022 | -84.82% |
| Dec 31, 2021 | -41.39% |
| Sep 30, 2021 | 49.14% |
| Jun 30, 2021 | 39.54% |